Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evgeny Krynetskiy

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pharmacogenomics|April 6, 2013
Institutional Profile: Jayne Haines Center for Pharmacogenomics and Drug Safety: educating future generations of healthcare professionalsEvgeny Krynetskiy
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
Building individualized medicine: prevention of adverse reactions to warfarin therapyEvgeny Krynetskiy, Patrick McDonnell
Concussion (London, England)|September 12, 2018
Genetic findings in sport-related concussions: potential for individualized medicine?Jane McDevitt, Evgeny Krynetskiy
American Journal of Pharmaceutical Education|August 7, 2009
Introducing pharmacy students to pharmacogenomic analysisEvgeny Krynetskiy, Ina Lee Calligaro
Anti-Cancer Drugs|February 5, 2013
Cytotoxicity of chemotherapeutic agents in glyceraldehyde-3-phosphate dehydrogenase-depleted human lung carcinoma A549 cells with the accelerated senescence phenotypeManali Phadke, Natalia Krynetskaia, Evgeny Krynetskiy
Foot & Ankle Specialist|July 2, 2013
The total ankle arthroplasty learning curve with third-generation implants: a single surgeon's experienceR Carter Clement, Evgeny Krynetskiy, Selene G Parekh
Biochemical and Biophysical Research Communications|July 14, 2011
Accelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cellsManali Phadke, Natalia Krynetskaia, Anurag Mishra, et al.
Molecular Pharmacology|October 24, 2007
High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugsNatalia Krynetskaia, Hongbo Xie, Slobodan Vucetic, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell linesManali S Phadke, Natalia F Krynetskaia, Anurag K Mishra, et al.
Life Sciences|April 10, 2013
Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairmentEvgeny Krynetskiy, Natalia Krynetskaia, Diana Rihawi, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|April 6, 2013
Institutional Profile: Jayne Haines Center for Pharmacogenomics and Drug Safety: educating future generations of healthcare professionalsEvgeny Krynetskiy
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
Building individualized medicine: prevention of adverse reactions to warfarin therapyEvgeny Krynetskiy, Patrick McDonnell
Concussion (London, England)|September 12, 2018
Genetic findings in sport-related concussions: potential for individualized medicine?Jane McDevitt, Evgeny Krynetskiy
American Journal of Pharmaceutical Education|August 7, 2009
Introducing pharmacy students to pharmacogenomic analysisEvgeny Krynetskiy, Ina Lee Calligaro
Anti-Cancer Drugs|February 5, 2013
Cytotoxicity of chemotherapeutic agents in glyceraldehyde-3-phosphate dehydrogenase-depleted human lung carcinoma A549 cells with the accelerated senescence phenotypeManali Phadke, Natalia Krynetskaia, Evgeny Krynetskiy
Foot & Ankle Specialist|July 2, 2013
The total ankle arthroplasty learning curve with third-generation implants: a single surgeon's experienceR Carter Clement, Evgeny Krynetskiy, Selene G Parekh
Biochemical and Biophysical Research Communications|July 14, 2011
Accelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cellsManali Phadke, Natalia Krynetskaia, Anurag Mishra, et al.
Molecular Pharmacology|October 24, 2007
High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugsNatalia Krynetskaia, Hongbo Xie, Slobodan Vucetic, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2009
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell linesManali S Phadke, Natalia F Krynetskaia, Anurag K Mishra, et al.
Life Sciences|April 10, 2013
Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairmentEvgeny Krynetskiy, Natalia Krynetskaia, Diana Rihawi, et al.
Pageof 3